ARP2_HUMAN - dbPTM
ARP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ARP2_HUMAN
UniProt AC P61160
Protein Name Actin-related protein 2
Gene Name ACTR2
Organism Homo sapiens (Human).
Sequence Length 394
Subcellular Localization Cytoplasm, cytoskeleton . Cell projection .
Protein Description Functions as ATP-binding component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Seems to contact the pointed end of the daughter actin filament..
Protein Sequence MDSQGRKVVVCDNGTGFVKCGYAGSNFPEHIFPALVGRPIIRSTTKVGNIEIKDLMVGDEASELRSMLEVNYPMENGIVRNWDDMKHLWDYTFGPEKLNIDTRNCKILLTEPPMNPTKNREKIVEVMFETYQFSGVYVAIQAVLTLYAQGLLTGVVVDSGDGVTHICPVYEGFSLPHLTRRLDIAGRDITRYLIKLLLLRGYAFNHSADFETVRMIKEKLCYVGYNIEQEQKLALETTVLVESYTLPDGRIIKVGGERFEAPEALFQPHLINVEGVGVAELLFNTIQAADIDTRSEFYKHIVLSGGSTMYPGLPSRLERELKQLYLERVLKGDVEKLSKFKIRIEDPPRRKHMVFLGGAVLADIMKDKDNFWMTRQEYQEKGVRVLEKLGVTVR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDSQGRKV
-------CCCCCCEE
11.4625944712
3Phosphorylation-----MDSQGRKVVV
-----CCCCCCEEEE
32.9827251275
7Malonylation-MDSQGRKVVVCDNG
-CCCCCCEEEEECCC
46.3226320211
7Acetylation-MDSQGRKVVVCDNG
-CCCCCCEEEEECCC
46.3227452117
7Ubiquitination-MDSQGRKVVVCDNG
-CCCCCCEEEEECCC
46.3233845483
11S-palmitoylationQGRKVVVCDNGTGFV
CCCEEEEECCCCCEE
1.9629575903
19MethylationDNGTGFVKCGYAGSN
CCCCCEEECCCCCCC
21.49-
19UbiquitinationDNGTGFVKCGYAGSN
CCCCCEEECCCCCCC
21.4921963094
22PhosphorylationTGFVKCGYAGSNFPE
CCEEECCCCCCCCCH
19.7720090780
43PhosphorylationVGRPIIRSTTKVGNI
CCCCEEECCCEECCE
29.9823312004
44PhosphorylationGRPIIRSTTKVGNIE
CCCEEECCCEECCEE
22.3123312004
45PhosphorylationRPIIRSTTKVGNIEI
CCEEECCCEECCEEE
25.6123312004
46UbiquitinationPIIRSTTKVGNIEIK
CEEECCCEECCEEEE
48.5123000965
53UbiquitinationKVGNIEIKDLMVGDE
EECCEEEEEEECCCH
31.8321906983
56SulfoxidationNIEIKDLMVGDEASE
CEEEEEEECCCHHHH
4.5521406390
62PhosphorylationLMVGDEASELRSMLE
EECCCHHHHHHHHHH
34.8128674151
66PhosphorylationDEASELRSMLEVNYP
CHHHHHHHHHHCCCC
40.1021406692
67 (in isoform 2)Phosphorylation-2.75-
72PhosphorylationRSMLEVNYPMENGIV
HHHHHCCCCCCCCCC
14.7721406692
86UbiquitinationVRNWDDMKHLWDYTF
CCCHHHCHHHHHHCC
42.4121906983
86AcetylationVRNWDDMKHLWDYTF
CCCHHHCHHHHHHCC
42.4126822725
91UbiquitinationDMKHLWDYTFGPEKL
HCHHHHHHCCCHHHC
7.7421963094
91PhosphorylationDMKHLWDYTFGPEKL
HCHHHHHHCCCHHHC
7.7428152594
92PhosphorylationMKHLWDYTFGPEKLN
CHHHHHHCCCHHHCC
21.4628152594
97UbiquitinationDYTFGPEKLNIDTRN
HHCCCHHHCCCCCCC
50.3921906983
102UbiquitinationPEKLNIDTRNCKILL
HHHCCCCCCCCEEEE
21.7121963094
106UbiquitinationNIDTRNCKILLTEPP
CCCCCCCEEEEECCC
39.6827667366
110PhosphorylationRNCKILLTEPPMNPT
CCCEEEEECCCCCCC
42.8920068231
111UbiquitinationNCKILLTEPPMNPTK
CCEEEEECCCCCCCC
47.5827667366
114SulfoxidationILLTEPPMNPTKNRE
EEEECCCCCCCCCHH
15.9830846556
117PhosphorylationTEPPMNPTKNREKIV
ECCCCCCCCCHHHHH
35.6323401153
118AcetylationEPPMNPTKNREKIVE
CCCCCCCCCHHHHHH
56.0925953088
118UbiquitinationEPPMNPTKNREKIVE
CCCCCCCCCHHHHHH
56.0923000965
118NeddylationEPPMNPTKNREKIVE
CCCCCCCCCHHHHHH
56.0932015554
122UbiquitinationNPTKNREKIVEVMFE
CCCCCHHHHHHHHHE
49.1423000965
122 (in isoform 2)Phosphorylation-49.1427251275
123UbiquitinationPTKNREKIVEVMFET
CCCCHHHHHHHHHEE
2.4723000965
123NeddylationPTKNREKIVEVMFET
CCCCHHHHHHHHHEE
2.4732015554
127UbiquitinationREKIVEVMFETYQFS
HHHHHHHHHEECCCC
1.2723000965
195UbiquitinationDITRYLIKLLLLRGY
HHHHHHHHHHHHHCC
30.4121906983
200UbiquitinationLIKLLLLRGYAFNHS
HHHHHHHHCCCCCCC
35.7322053931
202PhosphorylationKLLLLRGYAFNHSAD
HHHHHHCCCCCCCCC
11.1123312004
207PhosphorylationRGYAFNHSADFETVR
HCCCCCCCCCHHHHH
30.5528348404
212PhosphorylationNHSADFETVRMIKEK
CCCCCHHHHHHHHHH
17.2623312004
212 (in isoform 2)Phosphorylation-17.2627251275
217UbiquitinationFETVRMIKEKLCYVG
HHHHHHHHHHHHCCC
39.1822817900
219AcetylationTVRMIKEKLCYVGYN
HHHHHHHHHHCCCCC
38.5625953088
219UbiquitinationTVRMIKEKLCYVGYN
HHHHHHHHHHCCCCC
38.5621906983
222UbiquitinationMIKEKLCYVGYNIEQ
HHHHHHHCCCCCCHH
13.8222817900
222PhosphorylationMIKEKLCYVGYNIEQ
HHHHHHHCCCCCCHH
13.8228152594
224UbiquitinationKEKLCYVGYNIEQEQ
HHHHHCCCCCCHHHH
5.3621963094
225PhosphorylationEKLCYVGYNIEQEQK
HHHHCCCCCCHHHHH
11.7028152594
237PhosphorylationEQKLALETTVLVESY
HHHHHHEEEEEEEEE
24.05-
238PhosphorylationQKLALETTVLVESYT
HHHHHEEEEEEEEEE
11.49-
253UbiquitinationLPDGRIIKVGGERFE
CCCCCEEEECCEECC
32.2421906983
253AcetylationLPDGRIIKVGGERFE
CCCCCEEEECCEECC
32.2425953088
258UbiquitinationIIKVGGERFEAPEAL
EEEECCEECCCCHHH
37.6727667366
298PhosphorylationIDTRSEFYKHIVLSG
CCCHHHHHHHHEECC
9.5225332170
299MalonylationDTRSEFYKHIVLSGG
CCHHHHHHHHEECCC
31.9826320211
299AcetylationDTRSEFYKHIVLSGG
CCHHHHHHHHEECCC
31.9819608861
299UbiquitinationDTRSEFYKHIVLSGG
CCHHHHHHHHEECCC
31.9823000965
304UbiquitinationFYKHIVLSGGSTMYP
HHHHHEECCCCCCCC
30.1623000965
304AcetylationFYKHIVLSGGSTMYP
HHHHHEECCCCCCCC
30.1619608861
304PhosphorylationFYKHIVLSGGSTMYP
HHHHHEECCCCCCCC
30.1625332170
309SulfoxidationVLSGGSTMYPGLPSR
EECCCCCCCCCCCHH
3.9930846556
315O-linked_GlycosylationTMYPGLPSRLERELK
CCCCCCCHHHHHHHH
55.3230379171
315PhosphorylationTMYPGLPSRLERELK
CCCCCCCHHHHHHHH
55.3225332170
322AcetylationSRLERELKQLYLERV
HHHHHHHHHHHHHHH
33.2419608861
322UbiquitinationSRLERELKQLYLERV
HHHHHHHHHHHHHHH
33.2421906983
327AcetylationELKQLYLERVLKGDV
HHHHHHHHHHHCCCH
27.4719608861
327UbiquitinationELKQLYLERVLKGDV
HHHHHHHHHHHCCCH
27.4727667366
331SumoylationLYLERVLKGDVEKLS
HHHHHHHCCCHHHHH
50.65-
331UbiquitinationLYLERVLKGDVEKLS
HHHHHHHCCCHHHHH
50.6523000965
331SuccinylationLYLERVLKGDVEKLS
HHHHHHHCCCHHHHH
50.6523954790
331SumoylationLYLERVLKGDVEKLS
HHHHHHHCCCHHHHH
50.65-
336UbiquitinationVLKGDVEKLSKFKIR
HHCCCHHHHHCCEEE
58.8923000965
336AcetylationVLKGDVEKLSKFKIR
HHCCCHHHHHCCEEE
58.8925953088
339UbiquitinationGDVEKLSKFKIRIED
CCHHHHHCCEEEECC
62.2024816145
341UbiquitinationVEKLSKFKIRIEDPP
HHHHHCCEEEECCCC
34.5123000965
344UbiquitinationLSKFKIRIEDPPRRK
HHCCEEEECCCCCCC
8.8524816145
366UbiquitinationAVLADIMKDKDNFWM
HHHHHHHHCCCCCEE
63.0623000965
368UbiquitinationLADIMKDKDNFWMTR
HHHHHHCCCCCEECH
49.4023000965
368AcetylationLADIMKDKDNFWMTR
HHHHHHCCCCCEECH
49.4025953088
371UbiquitinationIMKDKDNFWMTRQEY
HHHCCCCCEECHHHH
7.2723000965
373UbiquitinationKDKDNFWMTRQEYQE
HCCCCCEECHHHHHH
1.6123000965
374PhosphorylationDKDNFWMTRQEYQEK
CCCCCEECHHHHHHH
21.5721406692
378PhosphorylationFWMTRQEYQEKGVRV
CEECHHHHHHHCCHH
17.40-
381NeddylationTRQEYQEKGVRVLEK
CHHHHHHHCCHHHHH
47.3732015554
381AcetylationTRQEYQEKGVRVLEK
CHHHHHHHCCHHHHH
47.3725953088
381UbiquitinationTRQEYQEKGVRVLEK
CHHHHHHHCCHHHHH
47.3721906983
386UbiquitinationQEKGVRVLEKLGVTV
HHHCCHHHHHHCCCC
3.1724816145
386NeddylationQEKGVRVLEKLGVTV
HHHCCHHHHHHCCCC
3.1732015554
388SumoylationKGVRVLEKLGVTVR-
HCCHHHHHHCCCCC-
46.51-
388AcetylationKGVRVLEKLGVTVR-
HCCHHHHHHCCCCC-
46.5127178108
388SumoylationKGVRVLEKLGVTVR-
HCCHHHHHHCCCCC-
46.51-
388UbiquitinationKGVRVLEKLGVTVR-
HCCHHHHHHCCCCC-
46.5123000965
393UbiquitinationLEKLGVTVR------
HHHHCCCCC------
6.7623000965

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
202YPhosphorylationKinaseMAP3K14Q99558
GPS
237TPhosphorylationKinaseMAP3K14Q99558
GPS
237TPhosphorylationKinasePLK4O00444
PSP
238TPhosphorylationKinaseMAP3K14Q99558
GPS
238TPhosphorylationKinasePLK4O00444
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ARP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ARP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ARP3_HUMANACTR3physical
22939629
ARPC4_HUMANARPC4physical
22939629
ARPC5_HUMANARPC5physical
22939629
ARPC2_HUMANARPC2physical
22939629
ARPC3_HUMANARPC3physical
22939629
ARP5L_HUMANARPC5Lphysical
22939629
COR1C_HUMANCORO1Cphysical
22939629
UBE2N_HUMANUBE2Nphysical
22939629
ELF5_HUMANELF5physical
21988832
ARP3_HUMANACTR3physical
22863883
HEM2_HUMANALADphysical
22863883
ARPC2_HUMANARPC2physical
22863883
ARPC4_HUMANARPC4physical
22863883
CALU_HUMANCALUphysical
22863883
CRTAP_HUMANCRTAPphysical
22863883
FUBP1_HUMANFUBP1physical
22863883
GRPE1_HUMANGRPEL1physical
22863883
HPBP1_HUMANHSPBP1physical
22863883
KBP_HUMANKIAA1279physical
22863883
TRMB_HUMANMETTL1physical
22863883
NIF3L_HUMANNIF3L1physical
22863883
NSUN2_HUMANNSUN2physical
22863883
OGT1_HUMANOGTphysical
22863883
PANK4_HUMANPANK4physical
22863883
PPME1_HUMANPPME1physical
22863883
KAPCB_HUMANPRKACBphysical
22863883
RAGP1_HUMANRANGAP1physical
22863883
RFA1_HUMANRPA1physical
22863883
RPR1A_HUMANRPRD1Aphysical
22863883
RPR1B_HUMANRPRD1Bphysical
22863883
SH3G1_HUMANSH3GL1physical
22863883
SHLB1_HUMANSH3GLB1physical
22863883
SRP09_HUMANSRP9physical
22863883
SURF2_HUMANSURF2physical
22863883
TM1L1_HUMANTOM1L1physical
22863883
PRPK_HUMANTP53RKphysical
22863883
TPD54_HUMANTPD52L2physical
22863883
TPRKB_HUMANTPRKBphysical
22863883
UFM1_HUMANUFM1physical
22863883
WDR4_HUMANWDR4physical
22863883
ZPR1_HUMANZPR1physical
22863883
ARP3_HUMANACTR3physical
26344197
ARPC2_HUMANARPC2physical
26344197
ARPC3_HUMANARPC3physical
26344197
ARPC4_HUMANARPC4physical
26344197
ARPC5_HUMANARPC5physical
26344197
ARP5L_HUMANARPC5Lphysical
26344197
CAZA2_HUMANCAPZA2physical
26344197
COR1B_HUMANCORO1Bphysical
26344197
FA98B_HUMANFAM98Bphysical
26344197
TCPZ_HUMANCCT6Aphysical
26496610
COF1_HUMANCFL1physical
26496610
CLCA_HUMANCLTAphysical
26496610
CLCB_HUMANCLTBphysical
26496610
DAB2_HUMANDAB2physical
26496610
DREB_HUMANDBN1physical
26496610
DSG2_HUMANDSG2physical
26496610
SRC8_HUMANCTTNphysical
26496610
GELS_HUMANGSNphysical
26496610
ITPR3_HUMANITPR3physical
26496610
MYO6_HUMANMYO6physical
26496610
MYPT1_HUMANPPP1R12Aphysical
26496610
SVIL_HUMANSVILphysical
26496610
TCPA_HUMANTCP1physical
26496610
TCPG_HUMANCCT3physical
26496610
LUZP1_HUMANLUZP1physical
26496610
RAI3_HUMANGPRC5Aphysical
26496610
ARPC5_HUMANARPC5physical
26496610
ARPC4_HUMANARPC4physical
26496610
ARPC3_HUMANARPC3physical
26496610
ARC1B_HUMANARPC1Bphysical
26496610
ARP3_HUMANACTR3physical
26496610
ARPC2_HUMANARPC2physical
26496610
BASP1_HUMANBASP1physical
26496610
ARC1A_HUMANARPC1Aphysical
26496610
TCPH_HUMANCCT7physical
26496610
TCPD_HUMANCCT4physical
26496610
TCPB_HUMANCCT2physical
26496610
TCPQ_HUMANCCT8physical
26496610
TCPE_HUMANCCT5physical
26496610
COBL_HUMANCOBLphysical
26496610
COR1C_HUMANCORO1Cphysical
26496610
LIMA1_HUMANLIMA1physical
26496610
RBM27_HUMANRBM27physical
26496610
MTA70_HUMANMETTL3physical
26496610
INF2_HUMANINF2physical
26496610
PDCL3_HUMANPDCL3physical
26496610
CYBR1_HUMANCYBRD1physical
26496610
ARP5L_HUMANARPC5Lphysical
26496610
CHUR_HUMANCHURC1physical
26496610
CYTSB_HUMANSPECC1physical
26496610
MISP_HUMANMISPphysical
26496610

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ARP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-299 AND LYS-322, AND MASSSPECTROMETRY.

TOP